DOREEN ABRIGO: Open Payments
NPI 1801361845 · WARNER ROBINS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,047 in 155 payments from 35 companies in 2025. Trend: 2023 $2,593 · 2024 $2,920 · 2025 $3,047
Food & beverage: $3,047
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 18 | $467 |
| ABBVIE INC. | 18 | $361 |
| PFIZER INC. | 16 | $291 |
| AstraZeneca Pharmaceuticals LP | 12 | $257 |
| Otsuka America Pharmaceutical, Inc. | 9 | $196 |
| Amgen Inc. | 12 | $161 |
| SHIELD THERAPEUTICS INC | 7 | $158 |
| Lundbeck LLC | 5 | $120 |
| Lilly USA, LLC | 9 | $109 |
| Merck Sharp & Dohme LLC | 4 | $84 |
Products named: REXULTI, ACCRUFER, NURTEC ODT, Ozempic, OTEZLA, FARXIGA, VRAYLAR, ELIQUIS.
Industry payments across GA — which companies pay providers there.
